2025 Nucleic Acid Amplification Testing Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Nucleic Acid Amplification Testing Industry Market Size Be by 2025?
There has been a rapid expansion in the size of the nucleic acid amplification testing market in the recent past. The market, which was valued at $9.56 billion in 2024, is projected to reach $11.03 billion in 2025, showing a compound annual growth rate (CAGR) of 15.3%. The historical growth has been influenced by factors such as increased awareness of diagnosis for infectious diseases, identification of new pathogens, the trend towards personalized medicine, demand for point-of-care testing, as well as regulatory approvals and guidelines.

What's the Long-Term Growth Forecast for the Nucleic Acid Amplification Testing Market Size Through 2029?
The market size for nucleic acid amplification testing is predicted to see a significant surge in the coming years, reaching $19.26 billion by 2029, with a CAGR of 15.0%. This anticipated growth over the forecast period could be due to an uptick in infectious diseases, the requirement for large-scale testing capabilities, more investment from private firms, a heightened demand for quick and accurate testing methods, and a surge in advanced diagnostic needs. The forecast period is expected to be marked by several key trends such as artificial intelligence integration, advancements in wearable and implantable devices, increased acceptance in point-of-care testing, growth in personalized medicine, and convergence with digital health technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-amplification-testing-global-market-report

What Are the Key Growth Drivers Fueling the Nucleic Acid Amplification Testing Market Expansion?
The escalating prevalence of communicable diseases is set to spur the expansion of the nucleic acid amplification testing market in the future. These diseases, which can be spread directly or indirectly via numerous means including physical contact, transmission through the air, unclean food or water, or via insects, are caused by microorganisms. The rise in such diseases is attributable to factors such as resistance to antibiotics, shifting climate conditions, modifications in human behavior, and changes in agricultural methods. Nucleic acid amplification testing (NAAT) aids in the rapid and accurate detection of infectious agents, thereby enabling prompt diagnosis and treatment, which assists in curtailing the proliferation of the diseases. For example, the Public Health Agency of Canada, a government agency based in Canada, disclosed that in the 2022-2023 season, provinces and territories that took part reported 4,216 influenza-related hospitalizations in October 2023. Consequently, the growing prevalence of infectious diseases is prompting the escalation of the nucleic acid amplification testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp

What Are the Key Trends Driving Nucleic Acid Amplification Testing Market Growth?
Primary players in the nucleic acid amplification testing market are concentrating their efforts on crafting innovative solutions, including in vitro diagnostics (IVD) assays. These assays are being designed to screen donated blood for CMV using nucleic acid amplification technology (NAT) under the IVDR framework. An IVD assay is a test used on biological specimens to identify diseases, conditions, or infections in a controlled external environment of a lab. To illustrate, GFE, a company based out of Germany, introduced PoET CMV in June 2024. This IVD assay, PoET CMV, is purpose-built for fast and accurate detection of cytomegalovirus (CMV) infections. Distinct features like high sensitivity and specificity make it ideal for early diagnosis and efficient monitoring of CMV in immunocompromised people and individuals receiving transplants. The assay employs state-of-the-art molecular methods to produce dependable results swiftly, thereby aiding immediate clinical decision-making.

How Is the Nucleic Acid Amplification Testing Market Segmented?
The nucleic acid amplification testingmarket covered in this report is segmented -

1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users

Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19619&type=smp

Which Companies Are Leading the Charge in Nucleic Acid Amplification Testing Market Innovation?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

Which Regions Are Leading the Global Nucleic Acid Amplification Testing Market in Revenue?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19619

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.